Literature DB >> 8895321

Evidence for negative cooperativity among human thyrotropin receptors overexpressed in mammalian cells.

G D Chazenbalk1, A Kakinuma, J C Jaume, S M McLachlan, B Rapoport.   

Abstract

The complementary DNA for the human TSH receptor (TSHR) translated region was amplified in the genome of stably transfected Chinese hamster ovary (CHO) cells using a dihydrofolate reductase minigene. Immunoprecipitation of TSHR in whole cells precursor-labeled with [35S]methionine and [35S]cysteine revealed an approximately 10-fold increase in TSHR expression in cells stabilized in 10,000 nM methotrexate (TSHR-10,000 cells) compared to cells with the same gene not subjected to amplification (TSHR-0 cells). Similarly, [125I]TSH cross-linking to the surface of intact CHO cells revealed a progressive increase in TSH-binding sites with dihydrofolate reductase minigene amplification, with a 12.8-fold increase in TSHR in TSHR-10,000 vs. TSHR-0 cells. Based on the known number of TSHR expressed by TSHR-0 cells, TSHR-10,000 express approximately 1.9 x 10(6) TSHR on their surface. Two ligand-TSHR complexes were evident under reducing conditions, representing the single chain holoreceptor of about 115 kDa and a dissociated A subunit of about 60 kDa. In the absence of TSH, basal cAMP levels in TSHR-10,000 cells were greater than those in TSHR-0 cells (6-fold in isotonic medium and 18.5-fold in hypotonic medium), indicating that the unliganded TSHR has significant constitutive activity. We assessed the kinetics of TSH binding to CHO cells overexpressing the TSHR using [125I]TSH in the presence of increasing concentrations of unlabeled TSH as well as by attempted saturation with labeled ligand. Surprisingly, in contrast to TSHR-0 cells (Kd = approximately 5 x 10(-10) M), we observed progressively lower affinities for TSH binding by TSHR-800 cells (Kd = approximately 10(-9) M) and TSHR-10,000 cells (Kd = approximately 2 x 10(-9) M). In summary, we report a high level of expression of TSHR in CHO cells and confirm the high constitutive activity of the TSHR in the absence of ligand as well as the binding of TSH to the single subunit, uncleaved TSHR. Moreover, we found that a high level of expression is associated with apparent negative cooperativity among the TSHR in terms of their affinity for ligand.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8895321     DOI: 10.1210/endo.137.11.8895321

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  24 in total

1.  Cytokines, IgG subclasses and costimulation in a mouse model of thyroid autoimmunity induced by injection of fibroblasts co-expressing MHC class II and thyroid autoantigens.

Authors:  X M Yan; J Guo; P Pichurin; K Tanaka; J C Jaume; B Rapoport; S M McLachlan
Journal:  Clin Exp Immunol       Date:  2000-11       Impact factor: 4.330

2.  Glycoprotein hormone receptors: link between receptor homodimerization and negative cooperativity.

Authors:  Eneko Urizar; Lucia Montanelli; Tiffany Loy; Marco Bonomi; Stéphane Swillens; Céline Gales; Michel Bouvier; Guillaume Smits; Gilbert Vassart; Sabine Costagliola
Journal:  EMBO J       Date:  2005-05-12       Impact factor: 11.598

3.  Evidence for activity-regulated hormone-binding cooperativity across glycoprotein hormone receptor homomers.

Authors:  Maxime Zoenen; Eneko Urizar; Stéphane Swillens; Gilbert Vassart; Sabine Costagliola
Journal:  Nat Commun       Date:  2012       Impact factor: 14.919

4.  Measurement of thyroid stimulating immunoglobulins using a novel thyroid stimulating hormone receptor-guanine nucleotide-binding protein, (GNAS) fusion bioassay.

Authors:  M Pierce; R Sandrock; G Gillespie; A W Meikle
Journal:  Clin Exp Immunol       Date:  2012-11       Impact factor: 4.330

5.  Thyroid-stimulating autoantibodies in Graves disease preferentially recognize the free A subunit, not the thyrotropin holoreceptor.

Authors:  Gregorio D Chazenbalk; Pavel Pichurin; Chun-Rong Chen; Francesco Latrofa; Alan P Johnstone; Sandra M McLachlan; Basil Rapoport
Journal:  J Clin Invest       Date:  2002-07       Impact factor: 14.808

6.  The DREAM protein is associated with thyroid enlargement and nodular development.

Authors:  Marcos Rivas; Britt Mellström; Begoña Torres; Gaetano Cali; Alfonso M Ferrara; Daniela Terracciano; Mariastella Zannini; Gabriella Morreale de Escobar; Jose R Naranjo
Journal:  Mol Endocrinol       Date:  2009-03-19

7.  A monoclonal antibody with thyrotropin (TSH) receptor inverse agonist and TSH antagonist activities binds to the receptor hinge region as well as to the leucine-rich domain.

Authors:  Chun-Rong Chen; Sandra M McLachlan; Basil Rapoport
Journal:  Endocrinology       Date:  2009-03-19       Impact factor: 4.736

8.  Identification of key amino acid residues in a thyrotropin receptor monoclonal antibody epitope provides insight into its inverse agonist and antagonist properties.

Authors:  Chun-Rong Chen; Sandra M McLachlan; Basil Rapoport
Journal:  Endocrinology       Date:  2008-04-03       Impact factor: 4.736

9.  A tyrosine residue on the TSH receptor stabilizes multimer formation.

Authors:  Rauf Latif; Krzysztof Michalek; Syed Ahmed Morshed; Terry F Davies
Journal:  PLoS One       Date:  2010-02-26       Impact factor: 3.240

Review 10.  TSH Receptor Cleavage Into Subunits and Shedding of the A-Subunit; A Molecular and Clinical Perspective.

Authors:  Basil Rapoport; Sandra M McLachlan
Journal:  Endocr Rev       Date:  2016-02       Impact factor: 19.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.